The goal of this clinical trial is to investigate the effectiveness of two treatments for adults with chronic low back pain. The main question this study seeks to answer is "In adults with chronic low back pain, what is the effectiveness of pain education and patient-led goal setting compared to guideline-based written advice on reducing pain intensity and disability?". A total of 392 participants will be randomised into two groups: 1) pain education and patient-led goal setting or 2) guideline-based written advice. Participants randomised to the pain education and patient-led goal setting group will receive 5 sessions of 45-60 min each over 8 weeks delivered online via telehealth. Participants randomised to written advice group will receive information developed for people with chronic low back pain. Outcomes will be assessed at baseline and week 8, 26 and 52.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
392
8 week program delivered via five, up to 1-hour telehealth sessions. The sessions will be scheduled at approximately fortnightly intervals. Participants will also be prescribed approximately 30 minutes of online activities with each session. Pain education will be based on Explain Pain and the curriculum will have specified learning objectives adapted for each individual participant. Participants will access the online education curriculum through Pathwright. For patient-led goal setting, the healthcare practitioner will take an initial history of the participants physical activity behaviours and problems related to their back pain. The participant will prioritise their problems according to impact in their life. Strategies will then be discussed, and the participant will, in collaboration with the healthcare practitioner, set goals and strategies to work on independently between sessions.
Participants will receive guideline-based written information for the management of chronic low back pain. This will include information about the prognosis of low back pain and treatment options to consider.
Neuroscience Research Australia
Sydney, New South Wales, Australia
RECRUITINGPain intensity
Average pain intensity over the previous 7 days assessed using the 11-point Numerical Pain Rating Scale
Time frame: Week 26 post-randomisation
Disability
Self-reported disability assessed using the Roland Morris Disability Questionnaire (RMDQ); scale range 0-24; lower scores indicate lower disability
Time frame: Week 26 post-randomisation
Pain intensity
Average pain intensity over the previous 7 days assessed using the 11-point Numerical Pain Rating Scale
Time frame: Weeks 8 and 52 post-randomisation
Disability
Self-reported disability assessed using the Roland Morris Disability Questionnaire (RMDQ); scale range 0-24; lower scores indicate lower disability
Time frame: Weeks 8 and 52 post-randomisation
Pain self-efficacy
Pain self-efficacy assessed using the Pain Self-Efficacy Questionnaire (PSEQ); scale range 0-60; higher scores indicate greater pain self-efficacy
Time frame: Weeks 8, 26 and 52 post-randomisation
Back beliefs
Back beliefs assessed using the Back Beliefs Questionnaire (BBQ); scale range 9-45, lower scores indicate more pessimistic beliefs about the consequences of low back pain
Time frame: Weeks 8, 26 and 52 post-randomisation
Kinesiophobia
Fear of movement (re)injury assessed by the short-form of the Tampa Scale of Kinesiophobia; scale range 4-16 (higher scores indicate greater kinesiophobia)
Time frame: Weeks 8, 26 and 52 post-randomisation
EuroQol 5-Dimension 5-Level (EQ-5D-5L)
Health-Related Quality of Life assessed using the EQ-5D-5L dimensions scale range, 1-5; higher scores indicate better quality of life) and health thermometer (range, 0-100; higher scores indicate better quality of life).
Time frame: Weeks 8, 26 and 52 post-randomisation
Daily step count
Average daily step count over the past 7 days assessed using accelerometry.
Time frame: Week 8 post-randomisation
Light intensity physical activity
Light intensity physical activity (min/day) over the past 7 days assessed using accelerometry
Time frame: Week 8 post-randomisation
Moderate-vigorous intensity physical activity
Moderate-vigorous intensity physical activity (min/day) over the past 7 days assessed using accelerometry
Time frame: Week 8 post-randomisation
Sedentary time
Sedentary time (min/day) over the past 7 days assessed using accelerometry
Time frame: Week 8 post-randomisation
Subjective physical activity levels
Self-reported physical activity over the previous 7 days assessed using the short-form of the International Physical Activity Questionnaire (IPAQ)
Time frame: Weeks 8, 26 and 52 post-randomisation
Lifestyle risk factors
Diet (do you eat less than two serves of fruit per day? (yes/no); do you eat less than fives serves of vegetables per day? (yes/no)). Alcohol intake (On average, how much alcohol do you drink each week? (I rarely/never drink alcohol; Less than 14 standard drinks; Between 14 and 21 standard drinks; More than 21 standard drinks)
Time frame: Weeks 8, 26 and 52 post-randomisation
Blood pressure
Blood pressure at rest assessed via an automated sphygmomanometer
Time frame: Week 8 post-randomisation
Adverse events
Adverse events assessed via self-report
Time frame: From randomisation to Week 8 post-randomisation
Adherence to treatment
Adherence to treatment assessed via session attendance and self-report (diary)
Time frame: From randomisation to Week 8 post-randomisation
Total healthcare costs
Total health-care costs will be estimated as the trial intervention costs and outside trial health-care resource use attributable to chronic low back pain from the Medicare Benefits Scheme and Pharmaceutical Benefits Scheme. Quality-adjusted life-years (QALYs) from the EQ-5D-5L using the Australian utility weights will also be used in the trial-based cost-utility analysis.
Time frame: Weeks 8, 26 and 52 post-randomisation
Goal attainment (goal setting arm only)
Goal attainment assessed using the goal attainment scale. Each goal is rated on a 5-point scale: +2 = much more than expected, +1 = somewhat more than expected, 0 = Patient achieves the expected level, -1 = somewhat less than expected, -2 = much less than expected.
Time frame: Weeks 8, 26 and 52 post-randomisation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.